The pharmaceutical industry and hospitals are fighting over the federally mandated 340B drug discount program. Some hospitals use the program as a revenue source instead of to help poor patients, drug industry groups say in a report. Hospitals argue that 340B was designed to stretch resources and support hospitals that serve the poor. Congressional Republicans are looking into the program.
Published in Brief: